This paper reports that PI3K functions upstream of RAS and that the inhibition of RAS signalling to ERK is required for PI3K inhibitors to induce apoptosis of cancer cells. Furthermore, intermittent treatment with PI3K inhibitors was sufficient to induce tumour regression in mice.